These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 2492166

  • 41. Panic disorder and agoraphobia. An update for primary care physicians.
    Anixter WL.
    N C Med J; 1988 Oct; 49(10):507-11. PubMed ID: 3054568
    [No Abstract] [Full Text] [Related]

  • 42. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
    Pyke RE, Greenberg HS.
    J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
    [Abstract] [Full Text] [Related]

  • 43. Pulsatile growth hormone secretion in patients with acromegaly and normal men: the effects of growth hormone-releasing hormone infusion.
    Gelato MC, Oldfield E, Loriaux DL, Merriam GR.
    J Clin Endocrinol Metab; 1990 Sep; 71(3):585-90. PubMed ID: 2118536
    [Abstract] [Full Text] [Related]

  • 44. Growth hormone-releasing hormone infusion in patients with active acromegaly.
    Losa M, Chiodini PG, Liuzzi A, König A, Müller OA, Schopohl J, von Werder K.
    J Clin Endocrinol Metab; 1986 Jul; 63(1):88-93. PubMed ID: 3086362
    [Abstract] [Full Text] [Related]

  • 45. Repetitive growth hormone-releasing hormone administration restores the attenuated growth hormone (GH) response to GH-releasing hormone testing in normal aging.
    Iovino M, Monteleone P, Steardo L.
    J Clin Endocrinol Metab; 1989 Oct; 69(4):910-3. PubMed ID: 2506218
    [Abstract] [Full Text] [Related]

  • 46. Situational panic attacks. Behavioral, physiologic, and biochemical characterization.
    Woods SW, Charney DS, McPherson CA, Gradman AH, Heninger GR.
    Arch Gen Psychiatry; 1987 Apr; 44(4):365-75. PubMed ID: 2882735
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients.
    Charney DS, Woods SW, Krystal JH, Nagy LM, Heninger GR.
    Acta Psychiatr Scand; 1992 Oct; 86(4):273-82. PubMed ID: 1333719
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Direct comparison of urinary free cortisol excretion in patients with depression and panic disorder.
    Kathol RG, Anton R, Noyes R, Gehris T.
    Biol Psychiatry; 1989 Apr 01; 25(7):873-8. PubMed ID: 2720002
    [Abstract] [Full Text] [Related]

  • 51. Human growth hormone releasing factor infusion effects on plasma growth hormone in affective disorder patients and normal controls.
    Risch SC, Ehlers C, Janowsky DS, Judd L, Gillin JC, Dana R, McAdams LA.
    Peptides; 1988 Apr 01; 9 Suppl 1():45-8. PubMed ID: 2856651
    [Abstract] [Full Text] [Related]

  • 52. Clinical and biological correlates of panic states.
    Lapierre YD.
    Prog Neuropsychopharmacol Biol Psychiatry; 1987 Apr 01; 11(2-3):91-6. PubMed ID: 3114829
    [Abstract] [Full Text] [Related]

  • 53. Psychophysiological factors in panic disorder.
    Freedman RR, Ianni P, Ettedgui E, Pohl R, Rainey JM.
    Psychopathology; 1984 Apr 01; 17 Suppl 1():66-73. PubMed ID: 6709797
    [Abstract] [Full Text] [Related]

  • 54. GH response to intravenous clonidine challenge correlates with history of childhood trauma in personality disorder.
    Lee RJ, Fanning JR, Coccaro EF.
    J Psychiatr Res; 2016 May 01; 76():38-43. PubMed ID: 26874268
    [Abstract] [Full Text] [Related]

  • 55. Cerebral ventricular size in panic disorder.
    Uhde TW, Kellner CH.
    J Affect Disord; 1987 May 01; 12(2):175-8. PubMed ID: 2955010
    [Abstract] [Full Text] [Related]

  • 56. Neuroendocrine effects of diazepam in panic and generalized anxiety disorders.
    Roy-Byrne PP, Cowley DS, Hommer D, Ritchie J, Greenblatt D, Nemeroff C.
    Biol Psychiatry; 1991 Jul 01; 30(1):73-80. PubMed ID: 1654136
    [Abstract] [Full Text] [Related]

  • 57. Panic disorders: clinical update 1984. Neuroendocrine aspects.
    Rubin RT.
    Psychosomatics; 1984 Oct 01; 25(10 Suppl):21-6. PubMed ID: 6390481
    [No Abstract] [Full Text] [Related]

  • 58. A kinetic analysis of platelet monoamine oxidase activity in patients with panic attacks.
    Norman TR, Acevedo A, McIntyre IM, Judd FK, Burrows GD.
    J Affect Disord; 1988 Oct 01; 15(2):127-30. PubMed ID: 2975682
    [Abstract] [Full Text] [Related]

  • 59. Growth hormone response to clonidine in male patients with panic disorder untreated by antidepressants.
    Schittecatte M, Ansseau M, Charles G, Machowski R, Papart P, Pichot W, Wilmotte J.
    Psychol Med; 1992 Nov 01; 22(4):1059-62. PubMed ID: 1488479
    [Abstract] [Full Text] [Related]

  • 60. HLA system and panic attacks.
    Cottraux J, Gebührer L, Bardi R, Betuel H.
    Biol Psychiatry; 1989 Feb 15; 25(4):505-8. PubMed ID: 2930815
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.